Completed PHASE4 INTERVENTIONAL 2-arm NCT02436980

Premedication for ERCP With Midazolam or Tramadol

Effects of Midazolam or Tramadol Premedication on Early Cognitive Function in ERCP: a Randomized Controlled Double-Blind Study

Sponsor: Karadeniz Technical University

Conditions Chronic Disease

Interventions Midazolam Tramadol

Updated 5 times since 2017 Last updated: May 12, 2015 Started: Jan 31, 2009 Primary completion: Sep 30, 2009 Completion: Dec 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02436980, this PHASE4 trial focuses on Chronic Disease and remains completed. Sponsored by Karadeniz Technical University, it has been updated 5 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jan 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Karadeniz Technical University

Data source: Karadeniz Technical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.